Azilsartan Ip/bp/ep/usp Cas No: 863031-21-4

NIiksanPharmaceutical is the worlda s leading pharmaceutical company in the manufacturing, supplying and exporting of Azilsartan Tablets and API. Niksan Pharmaceutical provides wide range of API and Finished pharmaceutical products of Azilsartan to the Niksan group companies and also to our customers in very affordable price.
Niksan Pharmaceuticalismanufacturer,supplier and exporter of the Azilsartan tablets in domestic and as well as worldwide.
Niksan Pharmaceuticalare manufacturing and supplying Azilsartan in the all over the Indians states like Punjab, Tamilnadu, Gujarat, Delhi, Uttar Pradesh, Bihar, Rajasthan, Maharashtra, west Bengal, Assam, Odisha.
NiksanPharmaceuticalis manufacturing and exporting Azilsartan from last many years in country like India, Portugal, Taiwan, United Arab Emirates, Mexico, Thailand, South Korea, China, United States, Canada, Germany, Vietnam, United Kingdom, Brazil, Egypt, Singapore, Jordan, Lebanon, Israel, Vietnam, Bangladesh, Paraguay, Argentina, Dominican Republic, Sudan, Hong Kong, Seychelles, Algeria, Iran, Bulgaria, Lithuania, Poland, Sri Lanka, Romania, Uruguay, Russia, Thailand, Afghanistan, Latvia, Lithuania, United Arab Emirates, Seychelles, Peru, Azerbaijan, Venezuela, Morocco, Cote D Ivories, St Lucia, South Korea, Congo, Philippines, Colombia, Burkina Faso, Sudan, Guinea, Djibouti, Netherlands, Nigeria and Germany.

Azilsartan represent the medicine class called angiotensin II receptor blockers (ARBs). It is widely use in treatment of hypertension (high blood pressure). Azilsartan lowers the blood pressure and helps to prevent heart attack and also use in prevention of kidney problems.
SYNONYMS: Azilsartan, Azilsartan kamedoxomil, Azilsartan mACdoxomil, Azilsartan Medoxomil, AzilsartA n medoxomilo, Azilsartanum medoxomilum
IUPAC NAME:(5-methyl-2-oxo-2H-1,3-dioxol-4-yl)methyl 2-ethoxy-1-({4-[2-(5-oxo-4,5-dihydro-1,2,4-oxadiazol-3-yl)phenyl]phenyl}methyl)-1H-1,3-benzodiazole-7-carboxylate
CAS NO: 863031-21-4
FORMULA: C30H24N4O8
MOLECULAR MASS: 568.53 g/mol
STORAGE: Store the medicine in room temperature away from moisture and light. Keep the medicine in the original container. Keep medicine away from children and pets.Properly discard this product when it is expired or no longer needed.
APPLICATION: Azilsartan is widely used in the treatment of the hypertension, it is use to lower the blood pressure in the body. It is used to prevent the heart strokes. Azilsartan is also used in the treatment of the kidney disease.
HOW TO USE: The dosage is based on your medical condition and response to treatment. Take this medication by mouth as directed by your doctor, usually once daily with or without food. Kindly dona t forget to take the medicine.

CONTRAINDICATIONS: Avoid the Azilsartan with Aliskiren. When it is used with combination with the Aliskiren in the patient with diabetes there are several risk of the increase of the adverse effects and also allergies. If any effect or allergy shown on the patient contact the prescriber or the nearby doctor.
SIDE EFFECTS: Normally the medicine is safe to use for the patient. But there are some adverse effect like diarrhoea, Dizziness, headache and also fatigue like symptoms are shown in the patient some time in patient.
There is no any serious adverse reaction are shown in patient using the Azilsartan. But if you notice some serious allergic reactions like rash, itching, swelling of (mouth, tongue, eyes) or any problems comes in breathing kindly contact and take advice from your doctor.
ABSORPTION:The normal absorption time of Azilsartan is 1.5-3 hrs.Usually the Azilsartan is not affected by the other factors like food or any peak plasma concentrations. The time of volume of distribution of the Azilsartan in 16 Litres. However the Azilsartan is a pro drug and the absolute bioavaibility of the Azilsartan in 60%.
TOXICITY: There is no any major toxic effects are known of Azilsartan however some time headache, problem in breathing are shown take the advice of your doctor.
CDSCO APPROVAL: Azilsartan formulation is approved by CDSCO in India in 16.02.2016 Azilsartan 40mg tablet and Azilsartan 80mg tablet.
FORMULATIONS IN MARKET:

Azilsartan 40mg tablet
Azilsartan 80mg tablet
Azilsartan Medoxomil salt tablet

Note: Product protected by valid patents are not offered for sale in countries where such patents are still valid and its liability is at Buyers Risk

REFERENCES:

www.webmd.com
https://pubchem.ncbi.nlm.nih.gov
https://go.drugbank.com
https://cdscoonline.gov.in
https://www.wikipedia.org/
https://www.drugs.com
https://www.zaubacorp.com
https://www.practo.com/consult